Garscadden Pharma Ltd - Period Ending 2022-10-31
Garscadden Pharma Ltd - Period Ending 2022-10-31
Registration number:
Garscadden Pharma Ltd
for the Period from 27 July 2022 to 31 October 2022
Garscadden Pharma Ltd
Contents
|
Company Information |
|
|
Accountants' Report |
|
|
Balance Sheet |
|
|
Notes to the Unaudited Financial Statements |
Garscadden Pharma Ltd
Company Information
|
Directors |
Mr Ronald Adrian Badger Mrs Lynne Barbara Badger |
|
Registered office |
|
|
Accountants |
|
Chartered Certified Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Garscadden Pharma Ltd
for the Period Ended 31 October 2022
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Garscadden Pharma Ltd for the period ended 31 October 2022 as set out on pages 3 to 3 from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants (ACCA), we are subject to its ethical and other professional requirements.
This report is made solely to the Board of Directors of Garscadden Pharma Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Garscadden Pharma Ltd and state those matters that we have agreed to state to the Board of Directors of Garscadden Pharma Ltd, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Garscadden Pharma Ltd and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Garscadden Pharma Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and results of Garscadden Pharma Ltd. You consider that Garscadden Pharma Ltd is exempt from the statutory audit requirement for the period.
We have not been instructed to carry out an audit or a review of the accounts of Garscadden Pharma Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
......................................
Chartered Certified Accountants
Bangor
Down
BT20 3AA
Garscadden Pharma Ltd
(Registration number: SC739479)
Balance Sheet as at 31 October 2022
|
2022 |
|
|
Current assets |
|
|
Prepayments and accrued income |
|
|
Creditors: Amounts falling due within one year |
( |
|
|
|
|
Capital and reserves |
|
For the financial period ending 31 October 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
|
• |
|
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved and authorised by the
|
......................................... |
Garscadden Pharma Ltd
|
General information |
The company is a private company limited by share capital, incorporated in Scotland.
The address of its registered office is:
Scotland
These financial statements were authorised for issue by the
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.
|
Staff numbers |
The average number of persons employed by the company (including directors) during the period, was